3rd EPIC- XS Webinar on Clinical Proteomics

Back to list May 07, 2021

3rd EPIC- XS Webinar on Clinical Proteomics



On 17 June 2021, the 3rd EPIC- XS Webinar entitled on Clinical Proteomics will take place.

The European Proteomics Infrastructure Consortium providing Access (EPIC-XS) consists of a unified network of experienced access providers and research groups who share a common goal: to facilitate the development and sustainability of proteomics exploration to all life science researchers within the European Union. The initiative is coordinated by the Utrecht University.

The Webinar will include:

  • A first series of talks on advances on Proteomics and Epi-proteomics profiling of clinical samples.
  • A second session on Clinical Phosphoproteomics and cancer proteomics.
  • A final round table on current perspective and challenges in clinical proteomics.

The past 2021 Webinars were a great success; don’t miss the event and join the 3rd EPIC-XS Webinar on Clinical Proteomics!

Registration is free and open until 11 June 2021, click here to sign up.

For more information, visit the EPIC-XS website and follow EPIC-XS on Twitter.

EPIC-XS has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 823839.





June 17th, 2021, 15:40-18:00

On Zoom


15.40 - 15.45   Welcome by Chairperson, Tiziana Bonaldi

15:45-16:45   Advances on Proteomics and Epi-proteomics profiling of clinical samples

First series of talks from the European Institute of Oncology IEO- Milano (Tiziana Bonaldi’s lab)- Milano, CNIO- Madrid (Javier Munoz’ lab), and the Imperial College- London (Luca Magnani’s lab)


Chair: Tiziana Bonaldi European Institute of Oncology (IEO)

15:45-16:00    Histone PTM and variant analysis from low abundance clinical samples - Roberta Noberini (IEO)

16:00-16:15   Revisiting the protein content of extracellular vesicles - Javier Munoz (CNIO)

16:15-16:30    Epigenomics to capture non-genetic adaptive strategies of dormant cells - Luca Magnani (Imperial College)

16:30-16:45    Q&A with the 3 speakers, moderated by Tiziana Bonaldi

16:45-16:50    Coffee break

16:50-18:00    Clinical Phosphoproteomics and new perspectives in cancer proteomics

Second series of talks from Pepscope - Utrecht, University of Copenhagen UCPH - Copenhagen (Jesper Olsen’s lab), and the Baylor College of Medicine BCM Houston, TX (Matthew Ellis’s lab, CPTAC)


Chair: Maarten Altelaar University of Utrecht

16:50-17:05    Direct kinase and pathway activity profling in breast cancer patients - Erik de Graaf (Pepscope, Utrecht)

17:05-17:20    Unraveling the phosphoproteome of patient-derived ovarian cancer stem cells - Giulia Franciosa (UCPH)

17:20-17:40    Proteogenomics of Breast Cancer: Clinical implication - Matthew Ellis (BCM, CPTAC)

17:40-17:55    Q&A with the 3 speakers, moderated by Maarten Altelaar

17.55-18:00    Wrap up and conclusions by Tiziana Bonaldi

Meeting Program